Wesley T. O’Neal et al. JACEP 2016;2:

Slides:



Advertisements
Similar presentations
Hazard of incident coronary heart disease by diabetes status, with or without elevation of troponin T No diabetes Pre- diabetes Diabetes No diabetes Pre-
Advertisements

Glucose Levels and Risk of Dementia Presented by - Anas Kabaha, MD Sheba medical center Sheba medical center August 8,2013.
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Does Elevated C-Reactive Protein Increase Atrial.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effects of Habitual Coffee Consumption on Cardiometabolic.
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Healthy Lifestyle and Decreasing Risk of Heart Failure.
From: Genetic Inhibition of CETP, Ischemic Vascular Disease and Mortality, and Possible Adverse Effects J Am Coll Cardiol. 2012;60(20): doi: /j.jacc
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation 
Copyright © 2014 American Medical Association. All rights reserved.
From: Statins and Cognitive FunctionA Systematic Review
All-cause mortality by treatment group
Copyright © 2007 American Medical Association. All rights reserved.
Copyright © 2007 American Medical Association. All rights reserved.
by Alexander Kulik, Ian G. Burwash, Varun Kapila, Thierry G
Hazard ratio (HR) for mortality for a 1-kg/m2 increase in body mass index (BMI) across the range of baseline BMI among patients with acute ischemic stroke.
James H. O’Keefe, MD, Salman K. Bhatti, MD, Ata Bajwa, MD, James J
Nat. Rev. Cardiol. doi: /nrcardio
Noriko Kikuchi et al. JACEP 2016;2:
Nat. Rev. Cardiol. doi: /nrcardio
The Burden of Modifiable Risk Factors in Newly Defined Categories of Blood Pressure  Anna Gu, MD, PhD, Yu Yue, PhD, Joohae Kim, PharmD Candidate, Edgar.
Endothelial Dysfunction in Patients With Lone AF and AF Patients With Comorbidities Compared With That in Controls Comparisons are shown among control.
Waddah Maskoun et al. JACEP 2016;2:
Konstantinos C. Siontis et al. JACEP 2016;2:
Shadi Al Halabi et al. JACEP 2015;1:
Cardiovascular Disease and CKD: Core Curriculum 2010
Ashish Shukla et al. JACEP 2015;1:41-51
Dileep Raman et al. JACEP 2017;3:
Simon W. Rabkin et al. JACEP 2017;j.jacep
Dhanunjaya Lakkireddy et al. JACEP 2015;1:
Volume 13, Issue 1, Pages 3-9 (January 2016)
Molly E. Waring, PhD, Jane S
OR (95% CI) for CHD associated with inflammatory markers in all participants and in subsets of non-users of statins or non-users of aspirin therapy. OR.
NAFLD (nonalcoholic fatty liver disease), CVD, and type 2 diabetes: Details of the study design Targher G et al. Diabetes Care 2007;30:
Mintu P. Turakhia et al. JACEP 2016;2:
Leonard M. Rademakers et al. JACEP 2016;2:
S.M. Afzal Sohaib et al. JACEP 2015;1:
Prabhat Kumar et al. JACEP 2016;j.jacep
Yoshitaka Kimura et al. JACEP 2016;2:
Vittorio Calzolari et al. JACEP 2017;3:
Connie W. Tsao et al. JCHF 2016;4:
P. Michael Grossman et al. JCIN 2009;2:
Moussa Mansour et al. JACEP 2016;j.jacep
Pamela E. Scott et al. JACC 2018;71:
Mintu P. Turakhia et al. JACEP 2016;2:
Simon W. Rabkin et al. JACEP 2017;3:
Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.
Exercise PA in MET-hours/week versus total leisure sedentary behavior in hours/day and incident type 2 diabetes mellitus from 2000 to Exercise PA.
Enrollment of patients.
Relative risk of a major coronary heart disease event (myocardial infarction incidence, fatal coronary heart disease, or coronary revascularization) for.
Forest plot showing the association between center-level characteristics and death-censored technique failure after adjusting for age, sex, race, body.
Davide Capodanno et al. JCIN 2009;2:
Connie W. Tsao et al. JCHF 2016;4:
Associations between type of MI and incident HF
Saadia Sherazi et al. JACEP 2015;1:74-80
Adjusted ORs of AF according to time since bereavement versus non-bereaved in a population from Denmark between 1995 and * *ORs are adjusted for.
Low/moderate intensity statins High intensity statins
Jeffrey Senfield et al. JACEP 2017;3:
Adjusted prevalence of CHD, atrial fibrillation, and stroke by sex and ethnic group. Numbers for sex are adjusted for age and clustering within practices.
Increase of physical activity over time associated with lower HF risk
Risk differences for incident stroke, coronary heart disease (CHD), and cardiovascular mortality (per 1000 person-years) by clinical risk factor in the.
Risk of venous thromboembolism by ABO blood type, factor V Leiden R506Q and prothrombin G20210A mutations among individuals in the Copenhagen General.
Orly Vardeny et al. JCHF 2016;4:
Risk of type 2 diabetes as a function of ABCA1 and ABCG1 genotype in CCHS. Hazard ratios were multifactorially adjusted for age, sex, BMI, hypertension,
Hazard ratios, with 95% confidence intervals as floating absolute risks, as estimate of association between category of updated mean haemoglobin A1c concentration.
Low/moderate intensity statins High intensity statins
Adjusted ORs of increasing severity of heartburn at follow-up in reference to baseline from model adjusted for BMI category, CVD history, BDI score >11,
HR for mortality in ischemic heart disease.
HR for myocardial infarction.
Increased incidence rate ratio (IRR) and 95% confidence intervals (CI) for type-specific community-acquired infections across eGFR categories within 12.
A – Demographic, Anthropometric and Clinical correlates of plasma NT-proBNP levels stratified by race: Multivariable Regression Results (Multivariable.
Presentation transcript:

Wesley T. O’Neal et al. JACEP 2016;2:645-652 Risk of Atrial Fibrillation Across Age-Predicted Maximum Heart Rate Each hazard ratio was computed with the median value for age-predicted maximum heart rate achieved of 91% as the reference; each was adjusted for age, sex, race, heart rate, smoking, hypertension, diabetes, obesity, hyperlipidemia, coronary heart disease, heart failure, antihypertensive medication use, lipid-lowering medication use, aspirin, and metabolic equivalent of task achieved. The dotted lines represent the 95% confidence intervals. Wesley T. O’Neal et al. JACEP 2016;2:645-652 American College of Cardiology Foundation